[1]乔新民,王丽君.血清CYFRA21-1，CA125，CA19-9 水平联合检测在胃癌诊断中的价值[J].现代检验医学杂志,2020,35(01):90-93.[doi:10.3969/j.issn.1671-7414.2020.01.024]
　QIAO Xin-min,WANG Li-jun.Value of Combined Detection of Serum CYFRA21-1, CA125 and CA19-9Levels in the Diagnosis of Gastric Cancer[J].Journal of Modern Laboratory Medicine,2020,35(01):90-93.[doi:10.3969/j.issn.1671-7414.2020.01.024]
点击复制

血清CYFRA21-1，CA125，CA19-9 水平联合检测在胃癌诊断中的价值()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第35卷
期数:
2020年01期
页码:
90-93
栏目:
论　　著
出版日期:
2020-02-29

文章信息/Info

Title:
Value of Combined Detection of Serum CYFRA21-1, CA125 and CA19-9 Levels in the Diagnosis of Gastric Cancer
文章编号:
1671-7414(2020)01-090-04
作者:
乔新民1; 王丽君2
(1.神木市医院消化内窥镜室, 陕西神木 719300; 2.西安市鄠邑区人民医院检验科,西安 710300)
Author(s):
QIAO Xin-min1;  WANG Li-jun2
( 1.Department of Digestive Endoscopy, Shenmu Hospital, Shaanxi Shenmu 719300,China; 2.Department of Clinical Laboratory, Xi'an City Huyi District People's Hospital, Xi'an 710300,China)
关键词:
细胞角蛋白19片段抗原21-1;  糖类抗原125;  糖类抗原19-9;  胃癌;  诊断
分类号:
R735.2; R730.43
DOI:
10.3969/j.issn.1671-7414.2020.01.024
文献标志码:
A
摘要:
目的 探讨血清中细胞角蛋白19片段抗原21-1(cytokeratin 19 fragment antigen21-1,CYFRA21-1),糖类抗原125(carbohydrate antigen,CA125)与CA19-9联合检测在胃癌诊断中的应用价值。方法 选择2017年8月～2019年6月在西安市鄠邑区人民医院诊治的良性胃肿瘤40例(良性组)和胃癌患者90例(胃癌组),检测所有患者的血清CYFRA21-1,CA125和CA19-9水平并判定异常情况,记录联合检测的结果。结果 胃癌组的血清CYFRA21-1,CA125和CA19-9含量均显著高于良性组,差异均有统计学意义(t=8.543～26.802,均P<0.05); 胃癌组CYFRA21-1,CA125和CA19-9的异常率及三指标联合检测的异常率均显著高于良性组,差异均有统计学意义(t=4.238～12.676,均P<0.05); Spearman等级相关分析显示胃癌与CYFRA21-1,CA125,CA19-9具有显著相关性(r=0.385～0.544,均P<0.05)。ROC曲线分析显示:CYFRA21-1,CA125,CA19-9与联合检测鉴别诊断胃癌的曲线下最大面积分别为0.766,0.674,0.714和0.844。结论 血清CYFRA21-1,CA125,CA19-9在胃癌中呈现高表达,与胃癌的发生显著相关,联合检测具有较好的诊断价值。
Abstract:
Objective To investigate the values of combined detection of serum Cytokeratin 19 fragment antigen 21-1(CYFRA 21-1), carbohydrate antigen 125(CA125)and carbohydrate antigen19-9(CA19-9)in the diagnosis of gastric cancer.Method From August2017 to June 2019, 40 cases of benign gastric neoplasms(benign group)and 90 cases of gastric cancer patients(gastric cancer group)were selected and treated in Xi'an City Huyi District People's Hospital. CYFRA21-1, CA125 and CA19-9 in the serum of all patients were detected to determine the positive rates and record the effect of joint detection. Results The levels of CYFRA21-1, CA125 and CA19-9 in the serum of gastric cancer group were significantly higher than those in the benign group,the difference wasstatistically significant(t=8.543～26.802, all P<0.05). The abnormal rates of CYFRA21-1, CA125 and CA19-9 in the gastric cancer group and the combined detection of the three indicators were significantly higher than those in the benign group,the difference wasstatistically significant(t=4.238～12.676, all P<0.05).Spearman rank correlation analysis showed that gastric cancer was associated with CYFRA21-1, CA125, CA19-9(r=0.385～0.544, all P<0.05). The ROC curve analysis showed that the maximum areas under the curve of CYFRA21-1, CA125, CA19-9 and combined detection for differential diagnosis of gastric cancer were 0.766, 0.674, 0.714 and 0.844.Conclusion The levels of CYFRA21-1, CA125 and CA19-9 in the serumare highly expressed in gastric cancer, which are significantly correlated with the occurrence of gastric cancer,and the combined detection have good diagnostic values.

参考文献/References:

[1] 黄莎,戴瑨,高娟娟,等.胃癌分子流行病学研究进展[J].中国肿瘤临床,2019,46(1):16-21. HUANG Sha, DAI Jin, GAO Juanjuan, et al. Research progress in the molecular epidemiology of gastric cancer [J] Chinese Journal of Clinical Oncology,2019,46(1):16-21.
[2] 范凝芳,崔雅丽,晋建华.血清同型半胱氨酸与相关肿瘤标志物对早期胃癌诊断及与进展期胃癌鉴别诊断的价值[J].中国药物与临床,2019,19(7):1160-1162. FAN Ningfang, CUI Yali, JIN Jianhua. The value of serum homocysteine and related tumor markers in the diagnosis of early gastric cancer and differential diagnosis of advanced gastric cancer[J]. Chinese Remedies & Clinics, 2019,19(7):1160-1162.
[3] 闫宏博,季福建,吴元玉,等.CEA,CA724,CA19-9对残胃癌诊断的意义及其相关性分析[J].中国实验诊断学,2019,23(2):207-210. YAN Hongbo, JI Fujian,WU Yuanyu, et al. The significance of CEA,CA724,CA19-9 to the diagnvsis of gastnc stump carcinoma and the analysis of the comelotion [J]. Chinese Journal of Laboratory Diagnosis,2019,23(2):207-210.
[4] 桂林,黄远帅.血清CA72-4,CA242,CA19-9和CEA的PCA-决策树模型对胃癌的诊断价值[J].现代检验医学杂志,2017,32(1):57-60. GUI Lin, HUANG Yuanshuai. Diagnostic value of serum CA72-4,CA242,CA19-9 and CEA for gastric cancer based on PCA-decision tree model [J].J Mod Lab Med,2017,32(1):57-60.
[5] YOSHIMURA A, UCHINO J, HASEGAWA K, et al. Carcinoembryonic antigen and CYFRA 21-1 responses as prognostic factors in advanced non-small cell lung cancer[J].Translational Lung Cancer Research, 2019, 8(3): 227-234.
[6] 何荣丽,李永旺,赵志英,等.CEA,CA125,CA19-9水平与胃癌患者病理学特点及术后转归的关系[J].河北医科大学学报,2019,40(6):709-712. HE Rongli, LI Yongwang, ZHAO Zhiying, et al. The relationship between CEA, CA125, CA19-9 levels and pathological features of gastric cancer patients and postoperative outcomes[J].Journal of Hebei Medical University, 2019,40(6):709-712.
[7] 刘红芬,王征,王莉,等.肿瘤标记物对胃癌诊断和预后判断的价值以及与免疫炎性反应指标的相关性[J].河北医科大学学报,2019,40(7):855-858. LIU Hongfen, WANG Zheng, WANG Li, et al. The value of tumor markers in the diagnosis and prognosis of gastric cancer and its correlation with immunoinflammatory response indicators [J]. Journal of Hebei Medical University, 2019, 40(7): 855-858.
[8] 施育鹏,潘妍.新辅助化疗对进展期胃癌患者血清VEGF,肿瘤标志物水平的影响[J].临床医学研究与实践,2019,4(17):7-9. SHI Yupeng, PAN Yan. Effect of neoadjuvant chemotherapy on the levels of serum VEGF and tumor markers in patients with advanced gastric cancer [J]. Clinical Research and Practice,2019,4(17):7-9.
[9] 陈国平,陈剑明.多项肿瘤标记物在胃癌诊断中的筛选及应用价值[J].福建医药杂志,2019,41(2):4-7. CHEN Guoping, CHEN Jianming. Value of screening and application of multiple combined tumor markers in the diagnosis of gastric cancer [J]. Fujian Medical Journal, 2019, 41(2): 4-7.
[10] SONG K S, NIMSE S B, WARKAD S D, et al. Quantification of CYFRA 21-1 and a CYFRA 21-1-anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer[J]. Chemical Communications(Cambridge, England), 2019, 55(68): 10060-10063.
[11] 伊万青.肿瘤标志物检验胃癌与病理检查分析[J].中西医结合心血管病杂志(电子版),2019,7(8):108. YI Wanqing. Analysis of gastric cancer and pathological examination by tumor markers[J]. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine(Electronic Edition), 2019,7(8):108.
[12] 韩莹波,崔丹,董红梅,等.血清MG-Ag,CEA,CA19-9和CA72-4联合检测对胃癌的诊断价值[J].中国实验诊断学,2019,23(3):426-427. HAN Yingbo, CUI Dan, DONG Hongmei, et al. Diagnostic value of combined detection of serum MG-Ag, CEA, CA19-9 and CA72-4 for gastric cancer[J]. Chinese Journal of Laboratory Diagnosis,2019,23(3):426 -427.
[13] 何荣丽,赵志英,刘超,等.肿瘤标志物在胃癌浸润深度评估及治疗决策中的价值[J].河北医科大学学报,2019,40(5):521-524. HE Rongli, ZHAO Zhiying, LIU Chao, et al. The value of tumor markers in the evaluation depth and treatment decision of gastric cancer [J].Journal of Hebei Medical University, 2019, 40(5): 521-524.
[14] 丽敏,孙鲁山,冯长梅,等.外周血人端粒酶反转录酶mRNA及四种肿瘤标志物检测在胃癌诊断中的价值[J].肿瘤研究与临床,2019,31(4):245-249. LI Min, SUN Lushan, FENG Changmei, et al. Diagnostic value of detection of peripheral blood human telomerase reverse transcriptase mRNA and four tumor markers in patients with gastric cancer [J].Cancer Research and Clinic,2019,31(4):245-249.
[15] 莫丽蓉,杨金芳,李雪,等.胃癌生物学标志物的相关研究进展[J].医学综述,2019,25(7):1327-1331,1337. MO Lirong, YANG Jinfang, LI Xue, et al. Research advances of biological markers on gastric cancer [J]. Medical Recapitulate, 2019, 25(7): 1327-1331, 1337.

相似文献/References:

[1]李 玲a,罗雅文a,何 霞a,等.子宫内膜癌患者BMI与血清HE4,CA125联合检测的诊断价值[J].现代检验医学杂志,2018,33(05):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
　LI Linga,LUO Ya-wena,HE Xiaa,et al.Diagnostic Value of Combined Detection of Body Mass Index and Serum HE4,CA125 in Patients with Endometrial Carcinoma[J].Journal of Modern Laboratory Medicine,2018,33(01):91.[doi:10.3969/j.issn.1671-7414.2018.05.024]
[2]马同敏,赵志强.血清CA125,STIP1和IGF-Ⅰ联合检测对卵巢癌的早期诊断价值研究[J].现代检验医学杂志,2018,33(06):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
　MA Tong-min,ZHAO Zhi-qiang.Clinical Value of Combined Detection of Serum CA125,STIP1 and IGF-I Levels in Early Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(01):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
[3]尹志辉,周志伟a,刘继勇a,等.乳腺癌患者组织多项组化标记物与血清CA153,CA125,CEA,25-OH-D3水平关联性分析模型建立及在预后判断的临床价值[J].现代检验医学杂志,2019,34(03):47.[doi:10.3969/j.issn.1671-7414.2019.03.011]
　YIN Zhi-hui,ZHOU Zhi-weia,LIU Ji-yonga,et al.Establishment of A Correlation Analysis Model betweenMulti-group Markers and Serum CA153,CA125,CEA,25-OH-D3in Breast Cancer Patients and Clinical Value in Prognosis[J].Journal of Modern Laboratory Medicine,2019,34(01):47.[doi:10.3969/j.issn.1671-7414.2019.03.011]
[4]张红雨,陆奉科,李 山,等.子宫内膜癌患者血清CA125 水平与外周血RDW 检测在临床病理分期中的应用价值[J].现代检验医学杂志,2020,35(01):94.[doi:10.3969/j.issn.1671-7414.2020.01.025]
　ZHANG Hong-yu,LU Feng-ke,LI Shan,et al.Value of Serum CA125 Level and Peripheral Blood RDW Detectionin Clinical Pathological Staging of Patients with Endometrial Cancer[J].Journal of Modern Laboratory Medicine,2020,35(01):94.[doi:10.3969/j.issn.1671-7414.2020.01.025]

备注/Memo

备注/Memo:
作者简介:乔新民(1962-),男,汉族,本科,副主任医师,研究方向:消化内科,电话:13289766018,E-mail:qxm13289766018@163.com。 通讯作者:王丽君(1972-),女,汉族,本科,主管检验师,研究方向:生化检验,电话:13572199611,E-mail:415817639@qq.com。收稿日期:2019-08-23 修回日期:2019-12-02
更新日期/Last Update: 2020-03-30